| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 19.829 | 24.618 | 20.695 | 6.373 | 7.477 | 19.945 | 17.050 | 8.910 |
| Total Income - EUR | - | - | 19.829 | 25.642 | 20.695 | 16.080 | 23.991 | 26.602 | 19.072 | 8.910 |
| Total Expenses - EUR | - | - | 16.642 | 40.187 | 20.379 | 20.473 | 23.708 | 22.433 | 18.465 | 12.430 |
| Gross Profit/Loss - EUR | - | - | 3.188 | -14.546 | 316 | -4.393 | 284 | 4.169 | 607 | -3.520 |
| Net Profit/Loss - EUR | - | - | 2.988 | -14.792 | 109 | -4.409 | 99 | 3.904 | 416 | -3.609 |
| Employees | - | - | 1 | 2 | 1 | 1 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Topexpoline Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 1.024 | 669 | 18.701 | 21.093 | 24.761 | 18.282 | 12.114 |
| Current Assets | - | - | 3.485 | 28.453 | 22.106 | 34.178 | 31.598 | 22.841 | 25.335 | 22.631 |
| Inventories | - | - | 0 | 22.089 | 15.251 | 14.352 | 13.494 | 12.779 | 12.169 | 12.006 |
| Receivables | - | - | 0 | 6.275 | 6.219 | 11.675 | 11.038 | 8.877 | 9.575 | 8.577 |
| Cash | - | - | 3.485 | 89 | 635 | 8.150 | 7.067 | 1.186 | 3.591 | 2.048 |
| Shareholders Funds | - | - | 3.032 | -11.816 | -11.478 | -15.670 | -15.223 | -11.366 | -10.916 | -14.464 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 453 | 41.293 | 34.253 | 68.550 | 67.915 | 58.969 | 54.532 | 49.209 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Topexpoline Srl